Status:
UNKNOWN
Occurrence of Emerging Infections After Placement of a Peritoneal Dialysis CatHeter
Lead Sponsor:
Centre Hospitalier Universitaire de Besancon
Conditions:
End Stage Renal Disease on Dialysis
Peritoneal Dialysis
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Peritoneal dialysis, which appeared at the end of the 1970s, quickly proved its worth both in terms of its effectiveness and of its ease of compliance, which guarantees an improved quality of life. To...
Eligibility Criteria
Inclusion
- Men and women aged 18 to 80 inclusive
- Signature of informed consent
- Affiliation to a French social security scheme
- Patient with end stage renal disease starting renal replacement therapy by peritoneal dialysis in one of the participating centers
Exclusion
- Legal incapacity or limited legal capacity
- Subject unlikely to cooperate with the study and / or weak cooperation anticipated by the investigator
- Pregnant woman
- Subject being in the period of exclusion from another study or provided for by the "national file of volunteers".
- Patient without health insurance
- Inability to understand the reasons for the study; psychiatric disorder judged by the investigator to be incompatible with inclusion in the study.
Key Trial Info
Start Date :
February 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04730830
Start Date
February 1 2021
End Date
August 1 2025
Last Update
August 2 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de néphrologie, CHU de Besançon
Besançon, France, 25000
2
Besancon University Hospital
Besançon, France, 25030